First-line everolimus followed by second-line sunitinib versus the opposite treatment sequence in patients with metastatic renal cell carcinoma (mRCC)+ Meeting Abstract


Authors: Knox, J. J.; Kay, A. C.; Schiff, E.; Hollaender, N.; Rouyrre, N.; Ravaud, A.; Motzer, R. J.
Abstract Title: First-line everolimus followed by second-line sunitinib versus the opposite treatment sequence in patients with metastatic renal cell carcinoma (mRCC)+
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 39s
Language: English
ACCESSION: WOS:000208852002232
DOI: 10.1200/jco.2010.28.15_suppl.tps232
PROVIDER: wos
Notes: Meeting Abstract: TPS232 -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer